An observational study in Malaria, sponsored by Bandim Health Project. Completed at 1 site in Guinea-Bissau. Open to participants aged Up to 15 Years. Per ClinicalTrials.gov, last updated 2021-05-26.
Sponsored by Bandim Health Project · Observational
The routine treatment of children with antimalarials will be monitored. Children with a positive malaria film and/or a positive rapid diagnostic test (RDT) will have a capillary blood sample taken to verify the diagnosis and to monitor the pattern of resistance.
Children from Bissau seeking medical advice and who are recommended treatment for malaria in accordance with the current routines will be included as follows:
All children getting the clinical diagnosis of malaria will be registered and basic information collected.
All children with a positive malaria film and/or a positive RDT will be asked for a capillary blood sample (app. 50 - 100 microliters on a filterpaper). Using PCR the parasitological diagnosis will be verified and if parasites are identified the resistance patterns will be examined. Both the capillary blood samples and the RDTs (if taken by the health staff) will be used in order to examine whether the RDTs can be used for routine monitoring of resistance in an area.
The study does not interfere in the routine treatment of the health staff. None of the children will be followed.
1,299 studies on the registry are indexed under Malaria; 86 are open to participants now.
This study's enrollment of 600 is close to the median of 600 across 218 observational studies indexed under Malaria.
Browse Malaria studies →Bandim Health Project is the lead sponsor of 59 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children seeking a health centre and by the health staff given the diagnosis: malaria and/or being treated with an antimalarial.
Exclusion Criteria:
Percentage of children treated for malaria with a parasitological confirmed malaria.
The blood samples will be analysed for parasites at the end of the study. The results do not have any impact on the treatment of the children.
Time frame: 6 weeks
Percentage of the parasites with mutations coding for resistance to antimalarials.
Time frame: 2 years
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bandim Health Project